Functional studies further support a critical role for GRP78 in GBM endothelial cells, as GRP78 knockdown increases tumor endothelial cell susceptibility to not only TMZ, but multiple chemotherapeutic agents, including CPT-11 and etoposide. This evidence concerns the gene HSPA5 and glioblastoma.